版本:
中国

BRIEF-Can-Fite reports new data on CF102'S liver protective & regenerative properties published in scientific journal

Sept 20 Can Fite Biopharma Ltd:

* CF102 is currently in global phase II trial for liver cancer and preparing for phase II trial in Nash

* Can-Fite reports new data on CF102'S liver protective & regenerative properties published in scientific journal

* Studies showed that CF102 protected liver against ischemic reperfusion manifested by a statistically significant reduction in key liver enzymes Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐